- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The IVD Infectious Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global IVD Infectious Disease market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Personal accounting for % of the IVD Infectious Disease global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biochemical Diagnosis segment is altered to a % CAGR between 2022 and 2028.
Global key companies of IVD Infectious Disease include Roche Diagnostics, Abbott Laboratories, Abbott, Gen-Probe, and Becton Dickinson (BD), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
IVD Infectious Disease market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other
Market segment by Application, can be divided into
Personal
Commercial
Academic
Other
Market segment by players, this report covers
Roche Diagnostics
Abbott Laboratories
Abbott
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe IVD Infectious Disease product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of IVD Infectious Disease, with revenue, gross margin and global market share of IVD Infectious Disease from 2019 to 2022.
Chapter 3, the IVD Infectious Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and IVD Infectious Disease market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe IVD Infectious Disease research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of IVD Infectious Disease
1.2 Classification of IVD Infectious Disease by Type
1.2.1 Overview: Global IVD Infectious Disease Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global IVD Infectious Disease Revenue Market Share by Type in 2021
1.2.3 Biochemical Diagnosis
1.2.4 Immune Diagnosis
1.2.5 Molecular Diagnosis
1.2.6 Microbiological Diagnosis
1.2.7 Urine Diagnosis
1.2.8 Coagulation Diagnosis
1.2.9 Other
1.3 Global IVD Infectious Disease Market by Application
1.3.1 Overview: Global IVD Infectious Disease Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Personal
1.3.3 Commercial
1.3.4 Academic
1.3.5 Other
1.4 Global IVD Infectious Disease Market Size & Forecast
1.5 Global IVD Infectious Disease Market Size and Forecast by Region
1.5.1 Global IVD Infectious Disease Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global IVD Infectious Disease Market Size by Region, (2017-2022)
1.5.3 North America IVD Infectious Disease Market Size and Prospect (2017-2028)
1.5.4 Europe IVD Infectious Disease Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific IVD Infectious Disease Market Size and Prospect (2017-2028)
1.5.6 South America IVD Infectious Disease Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa IVD Infectious Disease Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 IVD Infectious Disease Market Drivers
1.6.2 IVD Infectious Disease Market Restraints
1.6.3 IVD Infectious Disease Trends Analysis
2 Company Profiles
2.1 Roche Diagnostics
2.1.1 Roche Diagnostics Details
2.1.2 Roche Diagnostics Major Business
2.1.3 Roche Diagnostics IVD Infectious Disease Product and Solutions
2.1.4 Roche Diagnostics IVD Infectious Disease Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Roche Diagnostics Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories IVD Infectious Disease Product and Solutions
2.2.4 Abbott Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott IVD Infectious Disease Product and Solutions
2.3.4 Abbott IVD Infectious Disease Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Gen-Probe
2.4.1 Gen-Probe Details
2.4.2 Gen-Probe Major Business
2.4.3 Gen-Probe IVD Infectious Disease Product and Solutions
2.4.4 Gen-Probe IVD Infectious Disease Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Gen-Probe Recent Developments and Future Plans
2.5 Becton Dickinson (BD)
2.5.1 Becton Dickinson (BD) Details
2.5.2 Becton Dickinson (BD) Major Business
2.5.3 Becton Dickinson (BD) IVD Infectious Disease Product and Solutions
2.5.4 Becton Dickinson (BD) IVD Infectious Disease Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Becton Dickinson (BD) Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories IVD Infectious Disease Product and Solutions
2.6.4 Bio-Rad Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.7 Siemens Healthcare
2.7.1 Siemens Healthcare Details
2.7.2 Siemens Healthcare Major Business
2.7.3 Siemens Healthcare IVD Infectious Disease Product and Solutions
2.7.4 Siemens Healthcare IVD Infectious Disease Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Siemens Healthcare Recent Developments and Future Plans
2.8 Biomérieux
2.8.1 Biomérieux Details
2.8.2 Biomérieux Major Business
2.8.3 Biomérieux IVD Infectious Disease Product and Solutions
2.8.4 Biomérieux IVD Infectious Disease Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Biomérieux Recent Developments and Future Plans
2.9 Danaher
2.9.1 Danaher Details
2.9.2 Danaher Major Business
2.9.3 Danaher IVD Infectious Disease Product and Solutions
2.9.4 Danaher IVD Infectious Disease Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Danaher Recent Developments and Future Plans
2.10 Thermo Fisher
2.10.1 Thermo Fisher Details
2.10.2 Thermo Fisher Major Business
2.10.3 Thermo Fisher IVD Infectious Disease Product and Solutions
2.10.4 Thermo Fisher IVD Infectious Disease Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Thermo Fisher Recent Developments and Future Plans
2.11 Sysmex
2.11.1 Sysmex Details
2.11.2 Sysmex Major Business
2.11.3 Sysmex IVD Infectious Disease Product and Solutions
2.11.4 Sysmex IVD Infectious Disease Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Sysmex Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global IVD Infectious Disease Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 IVD Infectious Disease Players Market Share in 2021
3.2.2 Top 10 IVD Infectious Disease Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 IVD Infectious Disease Players Head Office, Products and Services Provided
3.4 IVD Infectious Disease Mergers & Acquisitions
3.5 IVD Infectious Disease New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global IVD Infectious Disease Revenue and Market Share by Type (2017-2022)
4.2 Global IVD Infectious Disease Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global IVD Infectious Disease Revenue Market Share by Application (2017-2022)
5.2 Global IVD Infectious Disease Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America IVD Infectious Disease Revenue by Type (2017-2028)
6.2 North America IVD Infectious Disease Revenue by Application (2017-2028)
6.3 North America IVD Infectious Disease Market Size by Country
6.3.1 North America IVD Infectious Disease Revenue by Country (2017-2028)
6.3.2 United States IVD Infectious Disease Market Size and Forecast (2017-2028)
6.3.3 Canada IVD Infectious Disease Market Size and Forecast (2017-2028)
6.3.4 Mexico IVD Infectious Disease Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe IVD Infectious Disease Revenue by Type (2017-2028)
7.2 Europe IVD Infectious Disease Revenue by Application (2017-2028)
7.3 Europe IVD Infectious Disease Market Size by Country
7.3.1 Europe IVD Infectious Disease Revenue by Country (2017-2028)
7.3.2 Germany IVD Infectious Disease Market Size and Forecast (2017-2028)
7.3.3 France IVD Infectious Disease Market Size and Forecast (2017-2028)
7.3.4 United Kingdom IVD Infectious Disease Market Size and Forecast (2017-2028)
7.3.5 Russia IVD Infectious Disease Market Size and Forecast (2017-2028)
7.3.6 Italy IVD Infectious Disease Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific IVD Infectious Disease Revenue by Type (2017-2028)
8.2 Asia-Pacific IVD Infectious Disease Revenue by Application (2017-2028)
8.3 Asia-Pacific IVD Infectious Disease Market Size by Region
8.3.1 Asia-Pacific IVD Infectious Disease Revenue by Region (2017-2028)
8.3.2 China IVD Infectious Disease Market Size and Forecast (2017-2028)
8.3.3 Japan IVD Infectious Disease Market Size and Forecast (2017-2028)
8.3.4 South Korea IVD Infectious Disease Market Size and Forecast (2017-2028)
8.3.5 India IVD Infectious Disease Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia IVD Infectious Disease Market Size and Forecast (2017-2028)
8.3.7 Australia IVD Infectious Disease Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America IVD Infectious Disease Revenue by Type (2017-2028)
9.2 South America IVD Infectious Disease Revenue by Application (2017-2028)
9.3 South America IVD Infectious Disease Market Size by Country
9.3.1 South America IVD Infectious Disease Revenue by Country (2017-2028)
9.3.2 Brazil IVD Infectious Disease Market Size and Forecast (2017-2028)
9.3.3 Argentina IVD Infectious Disease Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa IVD Infectious Disease Revenue by Type (2017-2028)
10.2 Middle East & Africa IVD Infectious Disease Revenue by Application (2017-2028)
10.3 Middle East & Africa IVD Infectious Disease Market Size by Country
10.3.1 Middle East & Africa IVD Infectious Disease Revenue by Country (2017-2028)
10.3.2 Turkey IVD Infectious Disease Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia IVD Infectious Disease Market Size and Forecast (2017-2028)
10.3.4 UAE IVD Infectious Disease Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global IVD Infectious Disease Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global IVD Infectious Disease Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market IVD Infectious Disease Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global IVD Infectious Disease Revenue (USD Million) by Region (2017-2022)
Table 5. Global IVD Infectious Disease Revenue Market Share by Region (2023-2028)
Table 6. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 7. Roche Diagnostics Major Business
Table 8. Roche Diagnostics IVD Infectious Disease Product and Solutions
Table 9. Roche Diagnostics IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories IVD Infectious Disease Product and Solutions
Table 13. Abbott Laboratories IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Abbott Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Major Business
Table 16. Abbott IVD Infectious Disease Product and Solutions
Table 17. Abbott IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Gen-Probe Corporate Information, Head Office, and Major Competitors
Table 19. Gen-Probe Major Business
Table 20. Gen-Probe IVD Infectious Disease Product and Solutions
Table 21. Gen-Probe IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Becton Dickinson (BD) Corporate Information, Head Office, and Major Competitors
Table 23. Becton Dickinson (BD) Major Business
Table 24. Becton Dickinson (BD) IVD Infectious Disease Product and Solutions
Table 25. Becton Dickinson (BD) IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Bio-Rad Laboratories Major Business
Table 28. Bio-Rad Laboratories IVD Infectious Disease Product and Solutions
Table 29. Bio-Rad Laboratories IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 31. Siemens Healthcare Major Business
Table 32. Siemens Healthcare IVD Infectious Disease Product and Solutions
Table 33. Siemens Healthcare IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Biomérieux Corporate Information, Head Office, and Major Competitors
Table 35. Biomérieux Major Business
Table 36. Biomérieux IVD Infectious Disease Product and Solutions
Table 37. Biomérieux IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Danaher Corporate Information, Head Office, and Major Competitors
Table 39. Danaher Major Business
Table 40. Danaher IVD Infectious Disease Product and Solutions
Table 41. Danaher IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Thermo Fisher Corporate Information, Head Office, and Major Competitors
Table 43. Thermo Fisher Major Business
Table 44. Thermo Fisher IVD Infectious Disease Product and Solutions
Table 45. Thermo Fisher IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Sysmex Corporate Information, Head Office, and Major Competitors
Table 47. Sysmex Major Business
Table 48. Sysmex IVD Infectious Disease Product and Solutions
Table 49. Sysmex IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Global IVD Infectious Disease Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 51. Global IVD Infectious Disease Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 52. Breakdown of IVD Infectious Disease by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. IVD Infectious Disease Players Head Office, Products and Services Provided
Table 54. IVD Infectious Disease Mergers & Acquisitions in the Past Five Years
Table 55. IVD Infectious Disease New Entrants and Expansion Plans
Table 56. Global IVD Infectious Disease Revenue (USD Million) by Type (2017-2022)
Table 57. Global IVD Infectious Disease Revenue Share by Type (2017-2022)
Table 58. Global IVD Infectious Disease Revenue Forecast by Type (2023-2028)
Table 59. Global IVD Infectious Disease Revenue by Application (2017-2022)
Table 60. Global IVD Infectious Disease Revenue Forecast by Application (2023-2028)
Table 61. North America IVD Infectious Disease Revenue by Type (2017-2022) & (USD Million)
Table 62. North America IVD Infectious Disease Revenue by Type (2023-2028) & (USD Million)
Table 63. North America IVD Infectious Disease Revenue by Application (2017-2022) & (USD Million)
Table 64. North America IVD Infectious Disease Revenue by Application (2023-2028) & (USD Million)
Table 65. North America IVD Infectious Disease Revenue by Country (2017-2022) & (USD Million)
Table 66. North America IVD Infectious Disease Revenue by Country (2023-2028) & (USD Million)
Table 67. Europe IVD Infectious Disease Revenue by Type (2017-2022) & (USD Million)
Table 68. Europe IVD Infectious Disease Revenue by Type (2023-2028) & (USD Million)
Table 69. Europe IVD Infectious Disease Revenue by Application (2017-2022) & (USD Million)
Table 70. Europe IVD Infectious Disease Revenue by Application (2023-2028) & (USD Million)
Table 71. Europe IVD Infectious Disease Revenue by Country (2017-2022) & (USD Million)
Table 72. Europe IVD Infectious Disease Revenue by Country (2023-2028) & (USD Million)
Table 73. Asia-Pacific IVD Infectious Disease Revenue by Type (2017-2022) & (USD Million)
Table 74. Asia-Pacific IVD Infectious Disease Revenue by Type (2023-2028) & (USD Million)
Table 75. Asia-Pacific IVD Infectious Disease Revenue by Application (2017-2022) & (USD Million)
Table 76. Asia-Pacific IVD Infectious Disease Revenue by Application (2023-2028) & (USD Million)
Table 77. Asia-Pacific IVD Infectious Disease Revenue by Region (2017-2022) & (USD Million)
Table 78. Asia-Pacific IVD Infectious Disease Revenue by Region (2023-2028) & (USD Million)
Table 79. South America IVD Infectious Disease Revenue by Type (2017-2022) & (USD Million)
Table 80. South America IVD Infectious Disease Revenue by Type (2023-2028) & (USD Million)
Table 81. South America IVD Infectious Disease Revenue by Application (2017-2022) & (USD Million)
Table 82. South America IVD Infectious Disease Revenue by Application (2023-2028) & (USD Million)
Table 83. South America IVD Infectious Disease Revenue by Country (2017-2022) & (USD Million)
Table 84. South America IVD Infectious Disease Revenue by Country (2023-2028) & (USD Million)
Table 85. Middle East & Africa IVD Infectious Disease Revenue by Type (2017-2022) & (USD Million)
Table 86. Middle East & Africa IVD Infectious Disease Revenue by Type (2023-2028) & (USD Million)
Table 87. Middle East & Africa IVD Infectious Disease Revenue by Application (2017-2022) & (USD Million)
Table 88. Middle East & Africa IVD Infectious Disease Revenue by Application (2023-2028) & (USD Million)
Table 89. Middle East & Africa IVD Infectious Disease Revenue by Country (2017-2022) & (USD Million)
Table 90. Middle East & Africa IVD Infectious Disease Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. IVD Infectious Disease Picture
Figure 2. Global IVD Infectious Disease Revenue Market Share by Type in 2021
Figure 3. Biochemical Diagnosis
Figure 4. Immune Diagnosis
Figure 5. Molecular Diagnosis
Figure 6. Microbiological Diagnosis
Figure 7. Urine Diagnosis
Figure 8. Coagulation Diagnosis
Figure 9. Other
Figure 10. IVD Infectious Disease Revenue Market Share by Application in 2021
Figure 11. Personal Picture
Figure 12. Commercial Picture
Figure 13. Academic Picture
Figure 14. Other Picture
Figure 15. Global IVD Infectious Disease Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 16. Global IVD Infectious Disease Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global IVD Infectious Disease Revenue Market Share by Region (2017-2028)
Figure 18. Global IVD Infectious Disease Revenue Market Share by Region in 2021
Figure 19. North America IVD Infectious Disease Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Europe IVD Infectious Disease Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Asia-Pacific IVD Infectious Disease Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. South America IVD Infectious Disease Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Middle East and Africa IVD Infectious Disease Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. IVD Infectious Disease Market Drivers
Figure 25. IVD Infectious Disease Market Restraints
Figure 26. IVD Infectious Disease Market Trends
Figure 27. Roche Diagnostics Recent Developments and Future Plans
Figure 28. Abbott Laboratories Recent Developments and Future Plans
Figure 29. Abbott Recent Developments and Future Plans
Figure 30. Gen-Probe Recent Developments and Future Plans
Figure 31. Becton Dickinson (BD) Recent Developments and Future Plans
Figure 32. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 33. Siemens Healthcare Recent Developments and Future Plans
Figure 34. Biomérieux Recent Developments and Future Plans
Figure 35. Danaher Recent Developments and Future Plans
Figure 36. Thermo Fisher Recent Developments and Future Plans
Figure 37. Sysmex Recent Developments and Future Plans
Figure 38. Global IVD Infectious Disease Revenue Share by Players in 2021
Figure 39. IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players IVD Infectious Disease Revenue Market Share in 2021
Figure 41. Global Top 10 Players IVD Infectious Disease Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global IVD Infectious Disease Revenue Share by Type in 2021
Figure 44. Global IVD Infectious Disease Market Share Forecast by Type (2023-2028)
Figure 45. Global IVD Infectious Disease Revenue Share by Application in 2021
Figure 46. Global IVD Infectious Disease Market Share Forecast by Application (2023-2028)
Figure 47. North America IVD Infectious Disease Sales Market Share by Type (2017-2028)
Figure 48. North America IVD Infectious Disease Sales Market Share by Application (2017-2028)
Figure 49. North America IVD Infectious Disease Revenue Market Share by Country (2017-2028)
Figure 50. United States IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe IVD Infectious Disease Sales Market Share by Type (2017-2028)
Figure 54. Europe IVD Infectious Disease Sales Market Share by Application (2017-2028)
Figure 55. Europe IVD Infectious Disease Revenue Market Share by Country (2017-2028)
Figure 56. Germany IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific IVD Infectious Disease Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific IVD Infectious Disease Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific IVD Infectious Disease Revenue Market Share by Region (2017-2028)
Figure 64. China IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America IVD Infectious Disease Sales Market Share by Type (2017-2028)
Figure 71. South America IVD Infectious Disease Sales Market Share by Application (2017-2028)
Figure 72. South America IVD Infectious Disease Revenue Market Share by Country (2017-2028)
Figure 73. Brazil IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa IVD Infectious Disease Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa IVD Infectious Disease Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa IVD Infectious Disease Revenue Market Share by Country (2017-2028)
Figure 78. Turkey IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE IVD Infectious Disease Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
